Albert Parker compensation by year
Insight Molecular Diagnostics Summary Compensation Table · all 2 fiscal years held| Component | FY2019 | FY2020 |
|---|---|---|
| Salary | $350,233 | $348,948 |
| Bonus | $57,120 | $133,465 |
| Option awards | $490,000 | $530,363 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $1,082 |
| All other | $14,000 | $386,135 |
| Total | $911,353 | $1,399,993 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Insight Molecular Diagnostics Inc. DEF 14A filed May 21, 2021, accession 0001493152-21-012508, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Insight Molecular Diagnostics Inc. filed document, accession 0001493152-21-012508. Every figure is read from that document and cited to the page and table it appears in. Filed May 21, 2021.
Insight Molecular Diagnostics’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Albert Parker · this page | Chief Operating Officer (15) | $1,399,993 |
| Mitchell Levine | Chief Financial Officer (11) | $1,058,460 |
| Ronald Andrews | President and Chief Executive Officer | $1,046,850 |
| Douglas Ross | Chief Science Officer | $980,437 |
| Padma Sundar | Senior Vice President, Marketing and Market Access (12) | $908,372 |
The full Insight Molecular Diagnostics compensation record
free company briefThis page is one person within Insight Molecular Diagnostics's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Insight Molecular Diagnostics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.